Patents by Inventor Itzhak D. Goldberg

Itzhak D. Goldberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for reducing angiogenesis by administration of a scatter factor inhibitor
    Patent number: 6432406
    Abstract: This invention relates to a method of enhancing wound healing and to a method of enhancing organ transplantation utilizing scatter factor, either alone or in combination with a growth factor.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: August 13, 2002
    Assignee: North Shore - Long Island Jewish Research Institute
    Inventors: Itzhak D. Goldberg, Eliot M. Rosen
  • Method for inducing the proliferation and migration of endothelial cells using scatter factor
    Patent number: 6013624
    Abstract: The present invention provides a novel method of inducing proliferation and migration of endothelial cells in a subject comprising administering an amount of scatter factor effective to induce the proliferation and migration of endothelial cells in the subject.
    Type: Grant
    Filed: November 25, 1998
    Date of Patent: January 11, 2000
    Assignee: North Shore University Hospital Research Corporation
    Inventors: Itzhak D. Goldberg, Eliot M. Rosen
  • Method for determining angiogenesis using scatter factor
    Patent number: 6011009
    Abstract: The present invention provides a novel method of determining the presence of angiogenesis in a subject comprising detecting the presence of scatter factor in the subject.
    Type: Grant
    Filed: November 25, 1998
    Date of Patent: January 4, 2000
    Assignee: North Shore University Hospital Research Corporation
    Inventors: Itzhak D. Goldberg, Eliot M. Rosen
  • Inhibition of scatter factor for blocking angiogenesis
    Patent number: 5997868
    Abstract: The present invention provides a novel method of inhibiting angiogenesis in a subject by blocking the ability of endogenous scatter factor to promote angiogenesis in the subject. The endogenous scatter factor may be blocked by using an inhibitor to scatter factor, such as an antibody.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: December 7, 1999
    Assignee: North Shore University Hospital Research Corporation
    Inventors: Itzhak D. Goldberg, Eliot M. Rosen
  • Method for enhancing transplanted tissue using scatter factor
    Patent number: 5965523
    Abstract: The present invention provides a novel method of enhancing transplanted tissue in a subject comprising administering an amount of scatter factor effective to promote angiogenesis and enhance tissue transplantation in the subject.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: October 12, 1999
    Assignee: North Shore University Hospital Research Corporation
    Inventors: Itzhak D. Goldberg, Eliot M. Rosen
  • Use of scatter factor to enhance angiogenesis
    Patent number: 5919759
    Abstract: This invention relates to a method of promoting angiogenesis utilizing scatter factor, either alone or in combination with a growth factor.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: July 6, 1999
    Assignee: North Shore University Hospital Research Corporation
    Inventors: Itzhak D. Goldberg, Eliot M. Rosen
  • Use of scatter factor to enhance angiogenesis
    Patent number: 5837676
    Abstract: This invention relates to a method of enhancing wound healing utilizing scatter factor, either alone or in combination with a growth factor.
    Type: Grant
    Filed: November 13, 1996
    Date of Patent: November 17, 1998
    Assignee: Long Island Jewish Medical Center
    Inventors: Itzhak D. Goldberg, Eliot M. Rosen
  • Method of diagnosing bladder cancer
    Patent number: 5656443
    Abstract: This invention relates to a method of diagnosing and screening for transitional cell carcinoma of the bladder. Urine from an individual suspected of having transitional cell carcinoma of the bladder is analyzed for the presence of an increased level of scatter factor, an increased level of scatter factor indicating that said individual has bladder cancer. This invention further relates to a method of monitoring bladder cancer activity by measuring the level of scatter factor in urine, and to a method of determining the prognosis of an individual having bladder cancer by measuring the level of scatter factor in tumor extract from the individual.
    Type: Grant
    Filed: July 29, 1994
    Date of Patent: August 12, 1997
    Assignee: Long Island Jewish Medical Center
    Inventors: Itzhak D. Goldberg, Eliot M. Rosen, Gary H. Weiss